Geron Corp reports results for the quarter ended June 30 - Earnings Summary

Geron

06/08/2025 14:31

Geron Corp GERN.OQ reported a quarterly adjusted loss of 2 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -10 cents.  The mean expectation of ten analysts for the quarter was for a loss of 3 cents per share. Wall Street expected results to range from -4 cents to -1 cents per share.

Revenue rose 5,459.6% to $49.04 million from a year ago; analysts expected $46.85 million.

Geron Corp's reported EPS for the quarter was a loss of 2 cents​.

The company reported a quarterly loss of $16.38 million.

Geron Corp shares had fallen by 14.9% this quarter and lost 66.1% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 0.2% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Geron Corp is $4.00, about 70% above its last closing price of $1.20

This summary was machine generated from LSEG data August 6 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
-0.03
-0.02
Beat
Mar. 31 2025
-0.04
-0.03
Beat
Dec. 31 2024
-0.05
-0.04
Beat
Sep. 30 2024
-0.08
-0.04
Beat